Abstract
Patients with diabetes mellitus are at an increased risk of silent myocardial infarction and are associated with poor outcome related to ventricular arrhythmias and sudden cardiac death. Although the cardiac sympathetic nervous system can be evaluated via the relatively simple and non-invasive assessment of heart rate variability, the evaluation with cardiac nuclear imaging using [123I]-metaiodobenzylguanidine ([123I]-MIBG) scintigraphy seems to be more sensitive. In addition, cardiac [123I]-MIBG-derived semiquantitative parameters are important predictors of outcome in patients with diabetes mellitus and heart failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CAD:
-
Coronary artery disease
- CAN:
-
Cardiac autonomic neuropathy
- DM:
-
Diabetes mellitus
- ECG:
-
Electrocardiogram
- H/M:
-
Heart/mediastinum
- HF:
-
Heart failure
- HRV:
-
Heart rate variability
- LV:
-
Left ventricle
- LVEF:
-
Left ventricular ejection fraction
- NYHA:
-
New York Heart Association
- PET:
-
Positron emission tomography
- RR:
-
R-wave to R-wave interval
- SPECT:
-
Single-photon emission computer tomography
References
American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care 21:1551–1559
American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31:S55–S60
Anan F, Takahashi N, Nakagawa M, Ooie T, Saikawa T, Yoshimatsu H (2005) High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Metabolism 54:552–558
Anan F, Takahashi N, Shinohara T et al (2006) Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur J Clin Invest 36:459–465
Anan F, Masaki T, Yonemochi H et al (2007a) Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 34:1189–1197
Anan F, Yonemochi H, Masaki T et al (2007b) Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients. Eur J Nucl Med Mol Imaging 34:28–35
Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223
Boulton AJ, Vinik AI, Arezzo JC et al (2005) Diabetic neuropathies: a statement by the American diabetes association. Diabetes Care 28:956–962
Clarke BF, Ewing DJ, Campbell IW (1979) Diabetic autonomic neuropathy. Diabetologia 17:195–212
Di Carli MF, Bianco-Batlles D, Landa ME et al (1999) Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 100:813–819
Ewing DJ, Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918
Ewing DJ, Campbell IW, Clarke BF (1976) Mortality in diabetic autonomic neuropathy. Lancet 1:601–603
Fallavollita JA, Canty JM Jr (2010) Dysinnervated but viable myocardium in ischemic heart disease. J Nucl Cardiol 17:1107–1115
Gerritsen J, Dekker JM, Ten Voorde BJ et al (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn study. Diabetes Care 24:1793–1798
Gerson MC, Caldwell JH, Ananthasubramaniam K et al (2011) Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 4:87–93
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
Hattori N, Tamaki N, Hayashi T et al (1996) Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 37:1985–1990
Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A (1997) Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 34:206–214
Jacobson AF, Senior R, Cerqueira MD et al (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol 55:2212–2221
Ji SY, Travin MI (2010) Radionuclide imaging of cardiac autonomic innervation. J Nucl Cardiol 17:655–666
Kontopoulos AG, Athyros VG, Didangelos TP et al (1997) Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care 20:355–361
Kreiner G, Wolzt M, Fasching P et al (1995) Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 44:543–549
Langer A, Freeman MR, Josse RG, Armstrong PW (1995) Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25:610–618
Nagamachi S, Jinnouchi S, Kurose T et al (2002) Serial change in 123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus. Ann Nucl Med 16:33–38
Nagamachi S, Fujita S, Nishii R et al (2006) Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol 13:34–42
Rose GA, Blackburn H (1968) Cardiovascular survey methods. Monogr Ser World Health Organ 56:1–188
Schnell O, Kirsch CM, Stemplinger J, Haslbeck M, Standl E (1995) Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38:1345–1352
Schnell O, Muhr D, Weiss M, Dresel S, Haslbeck M, Standl E (1996) Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45:801–805
Schnell O, Muhr D, Dresel S, Weiss M, Haslbeck M, Standl E (1997) Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up. Diabet Med 14:57–62
Schnell O, Hammer K, Muhr-Becker D et al (2002) Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy. J Diabetes Complications 16:220–227
Scholte AJ, Schuijf JD, Delgado V et al (2010) Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability. Eur J Nucl Med Mol Imaging 37:1698–1705
Scognamiglio R, Avogaro A, Casara D et al (1998) Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31:404–412
Scott LA, Kench PL (2004) Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis? J Nucl Med Technol 32:66–71
Stevens MJ, Raffel DM, Allman KC et al (1998) Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 98:961–968
The BARI Investigators (1997) Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 96:1761–1769
The BARI Investigators (2000) Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35:1122–1129
Turpeinen AK, Vanninen E, Kuikka JT, Uusitupa MI (1996) Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM. Diabetes Care 19:1083–1090
Valensi P, Sachs RN, Harfouche B et al (2001) Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339–343
Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115:387–397
Vinik AI, Maser RE, Mitchell BD, Freeman R (2003) Diabetic autonomic neuropathy. Diabetes Care 26:1553–1579
Website: http://www.diabetes.org/diabetes-statistics/prevalence.jsp. Consulted in 2009
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Ziegler D (1994) Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10:339–383
Ziegler D, Weise F, Langen KJ et al (1998) Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia 41:443–451
Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98:2334–2351
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scholte, A.J.H.A., Verberne, H.J. (2015). Imaging the Cardiac Automatic Nervous System in Diabetes Mellitus. In: Slart, R., Tio, R., Elsinga, P., Schwaiger, M. (eds) Autonomic Innervation of the Heart. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45074-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-45074-1_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45073-4
Online ISBN: 978-3-662-45074-1
eBook Packages: MedicineMedicine (R0)